Effects of chemotherapy on the cytogenetic constitution of Wilms' tumor

Clinical Cancer Research

Volumn 11, Issue 12, 2005, Pages 4382-4387

  Schlomm, Thorsten ^a   Gunawan, Bastian ^b   Schulten, Hans Jürgen ^b   Sander, Björn ^b   Thangavelu, Karthinathan ^b   Graf, Norbert ^c   Leuschner, Ivo ^d   Ringert, Rolf Hermann ^b   Füzesi, László ^b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEPHROBLASTOMA; NEWBORN; PREOPERATIVE TREATMENT; PRIORITY JOURNAL;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; SURVIVAL ANALYSIS; WILMS TUMOR;

EID: 20444487719     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-2123     Document Type: Article

References (44)

1. Pritchard-Jones K. Controversies and advances in the management of Wilms' tumour. Arch Dis Child 2002; 87:241-4.
2. Tournade MF, Com-Nougue C, Voute PA, et al. Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor. J Clin Oncol 1993; 11:1014-23.
3. Delemarre JF, Sandstedt B, Harms D, Boccon-Gibod L, Vujanic GM. The new SIOP (Stockholm) working classification of renal tumours of childhood. International Society of Paediatric Oncology. Med Pediatr Oncol 1996;26:145-6.
4. Godzinski J, Tournade MF, deKraker J, et al. Rarity of surgical complications after postchemotherapy nephrectomy for nephroblastoma. Experience of the International Society of Paediatric Oncology-Trial and Study "SIOP-9." International Society of Paediatric Oncology NephroblastomaTrial and Study Committee. Eur J Pediatr Surg 1998;8:83-6.
5. Graf N, Tournade MF, de Kraker J. The role of preoperative chemotherapy in the management of Wilms' tumor. The SIOP studies. International Society of Pediatric Oncology. Urol Clin North Am 2000;27:443-54.
6. Tournade MF, Com-Nougue C, de Kraker J, et al. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. J Clin Oncol 2001;19:488-500.
7. Weirich A, Leuschner I, Harms D, et al. Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH. Ann Oncol 2001;12:311-9.
8. Marx M, Langer T, Graf N, et al. Multicentre analysis of anthracycline-induced cardiotoxicity in children following treatment according to the nephroblastoma studies SIOP No. 9/GPOH and SIOP 93-01/ GPOH. Med Pediatr Oncol 2002;39:18-24.
9. Reinhard H, Semler O, Burger D, et al. Results of the SIOP 93-01/GPOH Trial and Study for the Treatment of Patients with Unilateral Nonmetastatic Wilms Tumor*. Klin Padiatr 2004;216:132-40.
10. Efferth T, Bode ME, Schulten HG, et al. Differential expression of the lung resistance-related protein/ major vault protein in the histological compartments of nephroblastomas. Int J Oncol 2001a;19:163-8.
11. Efferth T, Schulten HG, Thelen P, et al. Differential expression of the heat shock protein 70 in the histological compartments of nephroblastomas. Anticancer Res 2001c;21:2915-20.
12. Efferth T, Thelen P, Schulten HG, et al. Differential expression of the multidrug resistance-related protein MRP1 in the histological compartments of nephroblastomas. Int J Oncol 2001b;19:367-71.
13. Granzen B, Efferth T, Keller U, et al. Differential expression of the drug resistance markers DNA topoisomerase II α and glutathione 5-transferase-pi in the histological compartments of Wilms' tumors. Anticancer Res 2001;21:771-6.
14. Takahashi M, Yang XJ, Lavery TT, et al. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. Cancer Res 2002; 62:6598-605.
15. Klamt B, Schulze M, Thate C, et al. Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlate with clinicopathological parameters. Genes Chromosomes Cancer 1998;22:287-94.
16. Hing S, Lu YJ, Summersgill B, et al. Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors. Am J Pathol 2001;158:393-8.
17. Bown N, Cotterill SJ, Roberts P, et al. Cytogenetic abnormalities and clinical outcome in Wilms tumor: a study by the U.K. cancer cytogenetics group and the U.K. Children's Cancer Study Group. Med Pediatr Oncol 2002;38:11-21.
18. Peres EM, Savasan S, Cushing B, Abella S, Mohamed AN. Chromosome analyses of 16 cases of Wilms tumor: different pattern in unfavorable histology. Cancer Genet Cytogenet 2004;148:66-70.
19. Kalapurakal JA, Dome JS, Perlman EJ, et al. Management of Wilms' tumour: current practice and future goals. Lancet Oncol 2004;5:37-46.
20. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study. Cancer 1978;41:1937-48.
21. Gunawan B, Schulten HJ, von Heydebreck A, et al. Site-independent prognostic value of chromosome 9q loss in primary gastrointestinal stromal tumours. J Pathol 2004;202:421-9.
22. Kallioniemi OP, Kallioniemi A, Piper J, et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 1994;10:231-43.
23. Solinas-Toldo S, Wallrapp C, Muller-Pillasch F, et al. Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 1996;56:3803-7.
24. Betts DR, Koesters R, Plüss HJ, Niggli F. Routine karyotyping in Wilms tumors. Cancer Genet Cytogenet 1997;96:151-6.
25. Hoglund M, Gisselsson D, Hansen GB, Mitelman F. Wilms tumors develop through two distinct karyotypic pathways. Cancer Genet Cytogenet 2004;150:9-15.
26. Kullendorff CM, Soller M, Wiebe T, Mertens F. Cytogenetic findings and clinical course in a consecutive series of Wilms tumors. Cancer Genet Cytogenet 2003;140:82-7.
27. Mertens F, Johansson B, Hoglund M, Mitelman F. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res 1997;57:2765-80.
28. Sheng WW, Soukup S, Bove K, Gotwals B, Lampkin B. Chromosome analysis of 31 Wilms' tumors. Cancer Res 1990;50:2786-93.
29. Slater RM, Mannens MM. Cytogenetics and molecular genetics of Wilms' tumor of childhood. Cancer Genet Cytogenet 1992;61:111-21.
30. Solis V, Pritchard J, Cowell JK. Cytogenetic changes in Wilms' tumors. Cancer Genet Cytogenet 1988; 34:223-34.
31. Soukup S, Gotwals B, Blough R, Lampkin B. Wilms tumor: summary of 54 cytogenetic analyses. Cancer Genet Cytogenet 1997;97:169-71.
32. Nakadate H, Tsuchiya T, Maseki N, et al. Correlation of chromosome abnormalities with presence or absence of WT1 deletions/mutations in Wilms tumor. Genes Chromosomes Cancer 1999;25:26-32.
33. Altura RA, Valentine M, Li H, et al. Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization. Cancer Res 1996; 56:3837-41.
34. Getman ME, Houseal TW, Miller GA, et al. Comparative genomic hybridization and its application to Wilms' tumorigenesis. Cytogenet Cell Genet 1998; 82:284-90,
35. Steenman M, Redeker B, de Meulemeester M, et al. Comparative genomic hybridization analysis of Wilms tumors. Cytogenet Cell Genet 1997;77:296-303.
36. Kashiwagi H, Uchida K. Genome-wide profiling of gene amplification and deletion in cancer. Hum Cell 2000;13:135-41.
37. Fletcher JA, Renshaw AA. Isoohromosome 7q in adult Wilms' tumor. Cancer Genet Cytogenet 1996; 86:168-9.
38. Peier AM, Meloni AM, Erling MA, Sandberg AA. Involvement of chromosome 7 in Wilms tumor. Cancer Genet Cytogenet 1995;79:92-4.
39. Rubin BP, Pins MR, Nielsen GP, et al. Isochromosome 7q in adult Wilms' tumors: diagnostic and pathogenetic implications. Am J Surg Pathol 2000; 24:1663-9.
40. Sandoval C, Stringel G, Ozkaynak MF, Tugal O, Jayabose S. Isochromosome 7q and Wilms tumor. Cancer Genet Cytogenet 1998;104:61-5.
41. Sreekantaiah C, Beneck D. Isochromosomes 7q and 17q in Wilms tumor. Cancer Genet Cytogenet 1998; 106:84-6.
42. Grundy RG, Pritchard J, Scambler P, Cowell JK. Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour. Oncogene 1998; 17:395-400.
43. Wilmore HP, White GF, Howell RT, Brown KW. Germline and somatic abnormalities of chromosome 7 in Wilms' tumor. Cancer Genet Cytogenet 1994; 77:93-8.
44. Vernon EG, Malik K, Reynolds P, et al. The parathyroid hormone-responsive B1 gene is interrupted by a t(1;7)(q42;p15) breakpoint associated with Wilms' tumour. Oncogene 2003;22:1371-80.